These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13011064)

  • 1. Fatality due to agranulocytosis following use of phenylbutazone (butazolidin).
    ETESS AD; JACOBSON AS
    J Am Med Assoc; 1953 Feb; 151(8):639-40. PubMed ID: 13011064
    [No Abstract]   [Full Text] [Related]  

  • 2. Agranulocytosis following phenylbutazone (Butazolidin).
    BRANDWEIN S
    N Y State J Med; 1953 Jul; 53(13):1577-8. PubMed ID: 13072836
    [No Abstract]   [Full Text] [Related]  

  • 3. Agranulocytosis following use of phenylbutazone (butazolidin); report of a case.
    HINZ C; LAMONT-HAVERS RW; COMINSKY B; GAINES LM
    J Am Med Assoc; 1953 Jan; 151(1):38-9. PubMed ID: 12999503
    [No Abstract]   [Full Text] [Related]  

  • 4. Agranulocytosis following use of phenylbutazone (butazolidin).
    BERSHOF E; OXMAN AC
    J Am Med Assoc; 1953 Feb; 151(7):557-8. PubMed ID: 13011049
    [No Abstract]   [Full Text] [Related]  

  • 5. Agranulocytosis following administration of phenylbutazone (butazolidin).
    STIFEL JL; BURNHEIMER JC
    J Am Med Assoc; 1953 Feb; 151(7):555-6. PubMed ID: 13011047
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal agranulocytosis and gastric ulceration due to phenylbutazone.
    DILLING NV
    Lancet; 1953 Jun; 1(6773):1230-1. PubMed ID: 13053735
    [No Abstract]   [Full Text] [Related]  

  • 7. Death from hypersensitivity due to phenylbutazone.
    O'BRIEN DJ; STOREY G
    Br Med J; 1954 Apr; 1(4865):792-4. PubMed ID: 13140863
    [No Abstract]   [Full Text] [Related]  

  • 8. Deaths of two patients treated by phenylbutazone.
    BENSTEAD JG
    Br Med J; 1953 Mar; 1(4812):711-2. PubMed ID: 13032466
    [No Abstract]   [Full Text] [Related]  

  • 9. RISKS of butazolidin therapy.
    Br Med J; 1953 Jan; 1(4804):267. PubMed ID: 13009173
    [No Abstract]   [Full Text] [Related]  

  • 10. Agranulocytosis following phenylbutazone (butazolidin) therapy; report of a fatal case.
    STEINBERG CL; BOHROD MG; ROODENBURG AI
    J Am Med Assoc; 1953 May; 152(1):33-6. PubMed ID: 13034523
    [No Abstract]   [Full Text] [Related]  

  • 11. Agranulocytosis following phenylbutazone therapy.
    WERBLOW SC; NEBER J
    J Am Med Assoc; 1953 Apr; 151(15):1286-9. PubMed ID: 13034473
    [No Abstract]   [Full Text] [Related]  

  • 12. Agranulocytosis with recovery following the use of phenylbutazone (Butazolidin).
    ARCHER BH; KANTOR MG
    N Y State J Med; 1954 Feb; 54(3):394-5. PubMed ID: 13133104
    [No Abstract]   [Full Text] [Related]  

  • 13. Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis.
    STEPHENS CA; YEOMAN EE; HOLBROOK WP; HILL DF; GOODIN WL
    J Am Med Assoc; 1952 Nov; 150(11):1084-6. PubMed ID: 12990356
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenylbutazone (butazolidin) in rheumatoid arthritis and gout.
    KUZELL WC; SCHAFFARZICK RW; BROWN B; MANKLE EA
    J Am Med Assoc; 1952 Jun; 149(8):729-34. PubMed ID: 14927431
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylbutazone (butazolidin) and butapyrin; a study of clinical effects in arthritis and gout.
    KUZELL WC; SCHAFFARZICK RW
    Calif Med; 1952 Nov; 77(5):319-25. PubMed ID: 13009482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butazolidin in the treatment of arthritis; clinical studies with phenylbutazone.
    STRAZZA JA; RESSETAR M
    J Med Soc N J; 1953 Aug; 50(8):333-42. PubMed ID: 13069979
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the treatment of rheumatoid arthritis with butazolidin.
    CURRIE JP; BROWN RA; WILL G
    Ann Rheum Dis; 1953 Jun; 12(2):88-94. PubMed ID: 13058275
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenylbutazone: an evaluation of its use.
    SNOW WG
    Calif Med; 1953 Sep; 79(3):211-3. PubMed ID: 13082420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of butazolidin (phenylbutazone) on water and electrolyte excretion.
    WILKINSON EL; BROWN H
    Am J Med Sci; 1953 Feb; 225(2):153-8. PubMed ID: 13016556
    [No Abstract]   [Full Text] [Related]  

  • 20. Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.
    BRODIE BB; LOWMAN EW; BURNS JJ; LEE PR; CHENKIN T; GOLDMAN A; WEINER M; STEELE JM
    Am J Med; 1954 Feb; 16(2):181-90. PubMed ID: 13124349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.